InsidersTradesSigma
유유제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 유유제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 유유제약 has logged 67 insider filings. Market capitalisation: €59.7bn. The latest transaction was reported on 1 July 2026 (Other). Among the most active insiders: 유원상. Every trade is accessible without an account.
67
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
2 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 3,072 of 26,212 companies
72.3
score / 100
Value90
Quality54
FCF yld13%
Earn yld14%
EV/EBITDA5.0x
ROE6.8%
Gross mgn38%
Net mgn5.8%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations67 total
25 of 67 declarations
About 유유제약
유유제약 is a South Korean pharmaceutical company focused on the development and marketing of medications. It is listed on the KRX.